Drug
Nelitolimod sodium clinical trials
Also written SD-101 and TLR9 Agonist SD-101.
A product of Nelitolimod; its studies count on that page too.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Ronald Levy (2) · Robert Lowsky (1) · University of California, Davis (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses nelitolimod sodium is read from its arms, and is right about nine times in ten.
Testing it · 4
- TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin LymphomasCompletedPhase 1Ronald LevyNCT03410901Written as TLR9 Agonist SD-101
- TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular LymphomaCompletedPhase 1/2Robert LowskyNCT02927964Written as TLR9 Agonist SD-101
- SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid MalignanciesCompletedPhase 1Ronald LevyNCT03831295Written as TLR9 Agonist SD-101
- SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic CancerCompletedPhase 1University of California, DavisNCT04050085Written as TLR9 Agonist SD-101
Codes
What other systems call nelitolimod sodium · ClinicalTrials.gg INT017389
- UNII (FDA) NK22XIK2DPNELITOLIMOD SODIUMOne source FDA
- NCI Thesaurus C206947Nelitolimod SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NK22XIK2DP | NELITOLIMOD SODIUM | One source FDA |
| NCI Thesaurus | C206947 | Nelitolimod Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.